| Pregnancy |
1 |
1 |
| Breastfeeding |
0 |
0.48 |
| Congenital Anomaly |
0 |
0.35 |
| Breast |
0 |
0.33 |
| California |
0 |
0.33 |
| Renal Disease |
0 |
0.29 |
| Asthma |
0 |
0.28 |
| Birth |
0 |
0.25 |
| Kidney |
0 |
0.25 |
| Pruritus |
0 |
0.25 |
| Atypical Antipsychotics |
0 |
0.23 |
| Coronary Artery Disease (CAD) |
0 |
0.23 |
| Familial Hypercholesterolemia |
0 |
0.23 |
| Cardiovascular Risk Management |
0 |
0.22 |
| Chronic Kidney Disease |
0 |
0.2 |
| Renal Failure |
0 |
0.2 |
| Spontaneous Abortion |
0 |
0.2 |
| Lipids Management |
0 |
0.18 |
| Toxicology |
0 |
0.17 |
| Abortion |
0 |
0.16 |
| Adverse Effects |
0 |
0.16 |
| Antipsychotics |
0 |
0.16 |
| Child |
0 |
0.16 |
| Heart |
0 |
0.16 |
| Hypercholesterolemia |
0 |
0.16 |
| Washington |
0 |
0.16 |
| Contraception |
0 |
0.14 |
| Cytomegalovirus |
0 |
0.14 |
| Heart Failure (HF) |
0 |
0.13 |
| HIV Infection |
0 |
0.13 |
| African Trypanosomiasis |
0 |
0.12 |
| Hemodialysis |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Dermatitis |
0 |
0.11 |
| Fungal Infection |
0 |
0.11 |
| ADHD |
0 |
0.09 |
| Achondroplasia |
0 |
0.08 |
| Aducanumab |
0 |
0.08 |
| Alagille Syndrome |
0 |
0.08 |
| Animal Research |
0 |
0.08 |
| Atopic Dermatitis |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Central Nervous System |
0 |
0.08 |
| Glucocorticoid |
0 |
0.08 |
| Glycogen Storage Disease (GSD) Type II |
0 |
0.08 |
| Hypoglycemia |
0 |
0.08 |
| Information Center |
0 |
0.08 |
| Lupus |
0 |
0.08 |
| Nephritis |
0 |
0.08 |
| Parasite |
0 |
0.08 |
| Paroxysmal Nocturnal Hemoglobinuria |
0 |
0.08 |
| Polycythemia |
0 |
0.08 |
| Prostate |
0 |
0.08 |
| Prostate Cancer |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Short Stature |
0 |
0.08 |
| Skeletal |
0 |
0.08 |
| Stillbirth |
0 |
0.08 |
| Stimulants |
0 |
0.08 |
| Trypanosomiasis |
0 |
0.08 |
| Von Hippel-Lindau Disease |
0 |
0.08 |
| Vulvovaginal Candidiasis |
0 |
0.08 |
| Alzheimer Disease |
0 |
0.07 |
| Bipolar Disorder |
0 |
0.07 |
| Opioids |
0 |
0.07 |
| Tropical Diseases |
0 |
0.07 |
| Vasculitis |
0 |
0.07 |
| Polycythemia Vera |
0 |
0.06 |
| Severe Asthma |
0 |
0.06 |
| Skin and Soft Tissue Infection |
0 |
0.06 |
| Systemic Lupus Erythematosus |
0 |
0.06 |
| Biliary Disease |
0 |
0.04 |
| Candidiasis |
0 |
0.04 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Lysosomal Storage Disease |
0 |
0.04 |
| Migraine |
0 |
0.04 |
| Multiple Sclerosis |
0 |
0.04 |
| Muscular Atrophy |
0 |
0.04 |
| Myasthenia Gravis |
0 |
0.04 |
| Primary Immunodeficiency |
0 |
0.04 |
| Schizophrenia |
0 |
0.04 |
| Type 2 Diabetes Mellitus |
0 |
0.04 |